Detection method for characteristic chromatogram of Qingjin phlegm-reducing granules and characteristic chromatogram thereof
Through the HPLC-ELSD method and gradient elution conditions, the problem that the existing technology cannot control the quality of Platycodon, Fritillaria and Achieveins in Qingjin Huatan Decoction is solved, and the characteristic map detection of Qingjin Huatan Granules is achieved to ensure that It provides the simplicity of control of medicinal materials quality and daily inspection.
Patent Information
- Application Number
- CN202411535708.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-31
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2044-10-31
AI Technical Summary
The prior art cannot effectively control the quality of Platycodon, Fritillaria zheba and Anabola in Qingjin Huatan Decoction, and the existing methods are complex in operation and are not conducive to daily inspection.
Using HPLC-ELSD method, the platycodon saponin D reference and Qingjin Huatan Granule Test Solution was prepared, and the octadecyl silane bonded silica gel chromatography column was used, and the gradient elution conditions were acetonitrile and triethylamine mobile phase were detected. The characteristic map of Qingjin Huatan Granules was obtained to achieve quality control of Platycodon, Agnesium and Fritillaria zheba.
The calibration of the six characteristic peaks of Qingjin Huatan Granules is achieved, ensuring the control of the quality of medicinal materials, with special attributes, good repeatability and good stability, and is suitable for daily inspection.
Smart Images

Figure CN119044375A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of drug analysis, and particularly relates to a method for detecting a characteristic spectrum of Qingjin Huatan granules and the characteristic spectrum thereof. Background Art
[0002] Qingjin Huatan Decoction comes from "Medical Principles" by Ye Wenling in the Ming Dynasty. It has the effects of clearing away heat and detoxifying, clearing the liver and removing fire, relieving cough and reducing phlegm, relieving cough and relieving asthma, clearing the throat and relieving sore throat. It is composed of 11 medicinal ingredients including Scutellaria baicalensis, Gardenia jasminoides, Platycodon grandiflorum, Ophiopogon japonicus, Morus alba bark, Fritillaria thunbergii, Anemarrhena asphodeloides, Trichosanthes kirilowii, Citrus aurantium, Poria cocos, and Licorice. This prescription is the 56th prescription in the "Catalogue of Ancient Classic Prescriptions (First Batch)" released in April 2018.
[0003] The characteristic spectrum of traditional Chinese medicine is currently a widely accepted model for the quality evaluation of traditional Chinese medicine. Its application reflects the trend of comprehensive quality management of traditional Chinese medicine and conforms to the characteristics of overall characterization analysis of traditional Chinese medicine quality control. Therefore, the development of characteristic spectrum methods is particularly important for the quality control of Qingjin Huatan Decoction and its compound preparations.
[0004] Qingjin Huatan Decoction (QJHD) is a complex composition of 11 medicinal ingredients. Existing characterization methods, which often use DAD detectors, are unable to achieve quality control for Platycodon grandiflorum, Fritillaria thunbergii, and Anemarrhena rhizome. For example, in the paper "Study on the Material Benchmark Fingerprint and Multi-Indicator Content Determination of the Classic Recipe Qingjin Huatan Decoction," authors Li Yingman, Zhang Linlin, Zhu Qiang, et al., reported using a high-performance liquid chromatograph equipped with a DAD detector to establish a material benchmark fingerprint for QJHD. The fingerprint identified 23 shared peaks: peaks 1, 2, 3, 4, 6, 7, 8 (Gardenia jasminoides), 14, 15, 16, and 17 were attributed to Gardenia jasminoides; peak 5 was shared by Morus alba and Glycyrrhiza uralensis; peak 9 (Mangoside) was attributed to Anemarrhena rhizome; peak 10 was attributed to Glycyrrhiza uralensis; peaks 11, 18 (Baicalin), 19, 20, 21, 22, and 23 (Wogonin) were attributed to Scutellaria baicalensis; and peaks 12 and 13 (Hesperidin) were attributed to Citrus aurantium. This method controlled the quality of six medicinal materials, namely Gardenia jasminoides, Scutellaria baicalensis, Licorice, Morus alba bark, Citrus aurantium, and Anemarrhena asphodeloides, but failed to characterize the quality of Platycodon grandiflorum, Fritillaria thunbergii, Trichosanthes kirilowii, Ophiopogon japonicus, and Poria cocos. Only one characteristic peak of mangiferin was detected in Anemarrhena asphodeloides. The representative component of Anemarrhena asphodeloides, which is also the indicator component for content determination in the "Chinese Pharmacopoeia", Anemarrhena saponin BⅡ, was not controlled.
[0005] The article "HPLC-ELSD Determination of Fritillariae A and Fritillariae B in Jinbei Tankeqing Granules (Li Yueying, Yang Guoliang, et al.)" published in Volume 11, Issue 6, 2010, 446, employed high-performance liquid chromatography (HPLC-ELSD) to determine Fritillariae A and Fritillariae B, using an acetonitrile-water-diethylamine mobile phase for detection. This method contained 0.03% diethylamine in the mobile phase, a high concentration of which can easily damage the chromatographic column and detector. Furthermore, the method employed isocratic elution, focusing on the detection of Fritillariae A and Fritillariae B, and could only control the medicinal flavor of Fritillariae thunbergii. Furthermore, the preparation of the test solution required heating under reflux at 80°C for 2 hours, a complex and time-consuming procedure that was not suitable for routine testing. Summary of the Invention
[0006] The technical problem to be solved by the present invention is to overcome the above-mentioned defects of the prior art, provide a characteristic spectrum detection method for Qingjin Huatan granules, realize the quality control of Platycodon grandiflorum, Anemarrhena asphodeloides and Fritillaria thunbergii at the same time, and have the characteristics of strong specificity, good repeatability and good stability. The present invention also provides its characteristic spectrum.
[0007] The characteristic spectrum detection method of Qingjin Huatan granules of the present invention comprises the following steps: (1) Prepare a reference solution with Platycodon saponin D reference substance; (2) Prepare the test solution with Qingjin Huatan Granules; (3) The reference solution, the test solution, and the blank excipient solution were injected into a liquid chromatograph according to the following chromatographic conditions for measurement. The chromatograms of the reference solution and the test solution were obtained, and the retention times were compared to obtain the characteristic spectrum of Qingjin Huatan Granules. The chromatographic conditions are as follows: a chromatographic column filled with octadecylsilane bonded silica gel, an evaporative light scattering detector, acetonitrile as mobile phase A, and 0.008%-0.012% triethylamine solution as mobile phase B, with gradient elution at a flow rate of 0.9 mL / min-1.0 mL / min; and a column temperature of 33°C-37°C. The percentage of triethylamine solution is by volume.
[0008] The reference solution of step (1) is prepared by dissolving the Platycodonoside D reference substance in ethanol solution or methanol solution. Specifically, the Platycodonoside D reference substance is accurately weighed and added with 60% ethanol to prepare a reference solution containing 150 μg per 1 mL.
[0009] Preparation of the test solution in step (2): Take Qingjin Huatan Granules, first soak them in ammonia water, then add chloroform-methanol or dichloromethane-methanol mixed solution, ultrasonically treat, filter, evaporate the solid to dryness, and use ethanol solution or methanol solution to make up the volume. Specifically, take Qingjin Huatan Granules, grind them into powder, take 0.5g, accurately weigh, place in a stoppered conical flask, add 5mL of ammonia water to soak for 1h, accurately add chloroform-methanol or dichloromethane-methanol (volume ratio 4:1) ) 20mL of a mixed solution of ethanol and methanol, stopper, mix well, ultrasonicate or reflux for 45min-75min, cool, filter, and rinse the conical flask and filter paper with a mixed solution of chloroform-methanol or dichloromethane-methanol (volume ratio 4:1). Transfer all the solution to an evaporating dish, evaporate to dryness, dissolve the residue in ethanol solution or methanol solution and transfer it to a 5mL volumetric flask, dilute to the scale with ethanol solution or methanol solution, shake well, filter, and obtain the filtrate.
[0010] The gradient elution conditions of step (3) are: From 0 to 20 min, the volume fraction of mobile phase A changed from 20% to 25%, and the volume fraction of mobile phase B changed from 80% to 75%; 20-25 min, the volume fraction of mobile phase A changes from 25% to 25%, and the volume fraction of mobile phase B changes from 75% to 75%; From 25 to 43 min, the volume fraction of mobile phase A changed from 25% to 40%, and the volume fraction of mobile phase B changed from 75% to 60%; From 43 to 55 min, the volume fraction of mobile phase A changed from 40% to 70%, and the volume fraction of mobile phase B changed from 60% to 30%; From 55 to 75 min, the volume fraction of mobile phase A changed from 70% to 70%, and the volume fraction of mobile phase B changed from 30% to 30%.
[0011] The chromatographic conditions of step (3) also include: an injection volume of 30 μL; and a system suitability requirement: a theoretical plate number calculated based on the platycodon saponin D peak of not less than 3000.
[0012] The blank auxiliary material solution in step (3) is obtained by dissolving maltodextrin in ethanol solution or methanol solution. Specifically, 0.15 g of maltodextrin is dissolved in 60% ethanol and diluted to the scale, and shaken to obtain the blank auxiliary material solution.
[0013] The ethanol solution or methanol solution in step (1), step (2), and step (3) is preferably 60% ethanol, 30% methanol, 60% vt methanol, or 80% methanol, and more preferably 60% ethanol.
[0014] The chromatographic column used in step (3) was Thermo Acclaim™ 120 C18.
[0015] The evaporative light scattering detector model of step (3) is SEDEX 85 evaporative light detector.
[0016] A characteristic spectrum obtained by the characteristic spectrum detection method of Qingjin Huatan Granules: the test solution presents 6 characteristic peaks, with Peak 2 Platycodon saponin D peak as a reference, wherein Peak 1, Peak 4 and Peak 5 are derived from Anemarrhena asphodeloides medicinal material, Peak 2 and Peak 3 are derived from Platycodon grandiflorum medicinal material, and Peak 6 is derived from Fritillaria thunbergii medicinal material.
[0017] The six characteristic peaks were compared with the reference substances, and peak 1 was timosaponin BⅡ, peak 2 was platycodonosposide D, peak 5 was timosaponin AⅢ, and peak 6 was fritillin A.
[0018] The characteristic spectrum detection method of the Qingjin Huatan granules of the present invention was verified in the following aspects: 1. System suitability investigation: Take the reference solution, adopt the same chromatographic conditions as in the method, inject the sample 6 times continuously, record the chromatogram, and use the retention time and peak area RSD of the platycoside D peak as the investigation indicators.
[0019] 2. Specificity investigation: Take blank excipient solution, reference solution and test solution, use the same chromatographic conditions as in the method, record the chromatogram, and examine whether the test solution has chromatographic peaks at the reference peaks, and whether the blank excipient has interference at each characteristic peak.
[0020] 3. Repeatability investigation: Take the test solution and prepare 6 parallel portions. Use the same chromatographic conditions as in the method, inject each solution once, record the chromatogram, use Peak No. 2, Platycodon saponin D, as the reference, calculate the relative retention times of Peaks No. 1 and No. 3-6, and use the RSD of the relative retention time of each peak as the investigation indicator.
[0021] 4. Investigation of intermediate precision: Replace the analyst, prepare 6 parallel samples according to the preparation method of the test solution, replace another liquid chromatograph, adopt the same chromatographic conditions as in the method, inject each solution once, record the chromatogram, use Peak No. 2, Platycodon saponin D, as the reference, calculate the relative retention times of Peaks No. 1 and No. 3-6, and use the RSD of the relative retention time of each peak as the investigation indicator.
[0022] 5. Stability study of the test solution: Take the test solution and place it at room temperature for 0h, 2h, 4h, 8h, 12h, 24h, 36h, and 48h. Use the same chromatographic conditions as in the method, record the chromatogram, use Peak No. 2, Platycodon saponin D, as a reference, calculate the relative retention times of Peaks 1 and 3-6, and use the RSD of the relative retention time of each peak as the study indicator.
[0023] 6. Durability investigation: Take the test solution, take different column temperatures, different flow rates, different triethylamine concentrations, and different chromatographic columns, use the same chromatographic conditions as in the method, record the chromatogram, use Peak No. 2, Platycodon saponin D, as the reference, calculate the relative retention times of Peaks No. 1 and No. 3-6, and use the RSD of the relative retention time of each peak as the investigation indicator.
[0024] Compared with the prior art, the present invention has the following beneficial effects: (1) The characteristic spectrum detection method of Qingjin Huatan Granules of the present invention is established by using the HPLC-ELSD method. A total of 6 characteristic peaks are calibrated, and 4 characteristic components are identified, namely, platycodon saponin D, timosaponin BⅡ, timosaponin AⅢ, and fritillin A.
[0025] (2) The method of the present invention has good specificity, high precision, good reproducibility, good durability, and good solution stability, and can more comprehensively and effectively control the quality of Qingjin Huatan Decoction and its compound preparations, ensuring efficacy and medication safety. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Figure 1 This is the characteristic spectrum of the Qingjin Huatan Granules in Example 1.
[0027] Figure 2 This is the characteristic spectrum of Qingjin Huatan Granules obtained by the two extraction methods of ultrasonic treatment and reflux extraction in Example 2.
[0028] Figure 3 The characteristic spectra of the Qingjin Huatan granules in Example 3 with ultrasonic treatment times of 75 min, 1 h, and 45 min, respectively.
[0029] Figure 4 The characteristic spectra of Qingjin Huatan Granules when the extraction solvents of Example 4 are chloroform-methanol mixed solution and dichloromethane-methanol mixed solution respectively.
[0030] Figure 5 The characteristic spectra of Qingjin Huatan Granules with the extraction solvents of Example 5 being 80% methanol, 60% methanol, 30% methanol, 80% ethanol, 60% ethanol, and 30% ethanol, respectively.
[0031] Figure 6 This is a comparison chart of system suitability in method validation.
[0032] Figure 7 This is a comparison chart of specificity in method validation.
[0033] Figure 8 This is a comparison chart of repeatability in method validation.
[0034] Figure 9 This is a comparison chart of intermediate precision in method validation.
[0035] Figure 10 This is a stability comparison chart of the test solution in method validation.
[0036] Figure 11 This is a comparison chart of column temperature durability in method validation.
[0037] Figure 12 This is a comparison chart of flow rate durability in method validation.
[0038] Figure 13 This is a comparison chart of the durability of triethylamine concentration in mobile phase B during method validation.
[0039] Figure 14 This is a comparison chart of the durability of different chromatographic columns used in method validation. DETAILED DESCRIPTION
[0040] The present invention will be further described below with reference to specific embodiments.
[0041] The following instrument models are used: Liquid chromatograph: Thermo Ultimate 3000 high performance liquid chromatograph, Thermo Fisher Scientific Inc. Waters Arc high performance liquid chromatograph, Waters Company; Evaporative light detector: SEDEX 85 evaporative light detector, SEDERE, France; Weighing instrument: BCE951-10CN electronic balance, Beijing Sartorius Scientific Instrument Co., Ltd. AUW220D electronic balance, Shimadzu Corporation, Japan.
[0042] The following sources of medicines are used: Qingjin Huatan Granules: Shandong Qidu Pharmaceutical Co., Ltd., batch number: 2404002; Platycoside D: China Food and Drug Administration, batch number: 111851-202209, content: 97.3%; Anemarrhena saponin BⅡ: China Food and Drug Administration, batch number: 111839-202308, content: 93.2%; Anemarrhena saponin AⅢ: Chengdu Pusi Biotechnology Co., Ltd., batch number: PS011471, purity: 98.67%; Fritillaria cirrhosae: China Food and Drug Administration, batch number: 110750-201913, content: 98.4%; Methanol: Chengdu Kelong Chemical Reagent Co., Ltd., batch number: 2024041901; Acetonitrile: Chengdu Kelong Chemical Reagent Co., Ltd., batch number: 2024022902; Ethanol: Chengdu Kelong Chemical Reagent Co., Ltd., batch number: 2024011501; Ammonia: Chengdu Kelong Chemical Reagent Co., Ltd., batch number: 2023103001; Chloroform: Chengdu Jinshan Chemical Reagent Co., Ltd., batch number: 20230918; Triethylamine: DIKMA, batch number: 8184474; Maltodextrin: Xi'an Tianzheng Pharmaceutical Excipients Co., Ltd., batch number: 2023050151.
[0043] The % in the present invention refers to volume percentage.
[0044] Example 1 The method for detecting the characteristic spectrum of the Qingjin Huatan granules comprises the following steps: (1) Prepare the reference solution: Take Platycodon saponin D reference substance, weigh it accurately, and add 60% ethanol to make a reference solution containing 150 μg per 1 mL.
[0045] (2) Prepare the test solution: Take Qingjin Huatan Granules and soak them with ammonia water first, then add chloroform-methanol mixed solution, ultrasonically treat, filter, evaporate the solid to dryness, and use 60% ethanol to make up the volume. Specifically: Take Qingjin Huatan Granules, grind them into powder, take 0.5g, accurately weigh, place in a stoppered conical flask, add 5mL of ammonia water to soak for 1h, accurately add 20mL of chloroform-methanol (volume ratio 4:1) mixed solution, seal, mix, ultrasonically treat for 1h, let cool, filter, and rinse the conical flask and filter paper with chloroform-methanol (volume ratio 4:1) mixed solution, transfer all the solution to an evaporating dish, evaporate to dryness, add 60% ethanol to dissolve the residue and transfer it to a 5mL volumetric flask, dilute to the scale with 60% ethanol, shake well, filter, and take the filtrate.
[0046] (3) Prepare blank auxiliary material solution: Take 0.15g of maltodextrin, dissolve it in 60% ethanol and dilute to the scale, shake well.
[0047] (4) The reference solution, the test solution, and the blank excipient solution were injected into a Thermo Ultimate 3000 high performance liquid chromatograph according to the following chromatographic conditions: a Thermo Acclaim™ 120 C18 column, a SEDEX 85 evaporative light detector, acetonitrile as mobile phase A, 0.01% triethylamine solution as mobile phase B, gradient elution, the gradient elution conditions were as shown in Table 1, the flow rate was 1.0 mL / min; the column temperature was 35°C, and the injection volume was 30 μL; the system suitability requirement was: the number of theoretical plates calculated based on the platycoside D peak was not less than 3000.
[0048] Table 1 Gradient elution
[0049] The determination was performed to obtain the chromatograms of the reference solution and the test solution respectively; The retention time of the chromatogram of the test solution is compared with the retention time of the chromatogram of the reference solution to obtain the characteristic spectrum of the Qingjin Huatan granules, such as Figure 1 As shown, the chromatogram of the test solution showed 6 characteristic peaks, among which the peak corresponding to the platycodon saponin D reference peak was the S peak. The relative retention times of each characteristic peak and the S peak (peak 2) (characteristic peak / S peak) were calculated to be 0.68 (peak 1), 1.03 (peak 3), 1.18 (peak 4), 1.65 (peak 5), and 1.92 (peak 6), respectively. The relative retention times were all within ±10%, which met the specified values.
[0050] Example 2 The detection steps in this embodiment are the same as those in embodiment 1, except that the "ultrasonic treatment for 1 h" in the preparation of the test solution in step (2) of embodiment 1 is replaced by "reflux extraction for 1 h". The other steps are the same. The characteristic spectra of the two extraction methods are as follows: Figure 2 (From top to bottom, the extraction methods are ultrasound and reflux) as shown. Figure 2 It can be seen that the extraction effects of heating reflux and ultrasonic extraction are basically the same. In order to facilitate experimental operation, ultrasonic extraction is the preferred extraction method.
[0051] Example 3 The detection steps in this embodiment are the same as those in embodiment 1. In the preparation of the test solution in step (2) of embodiment 1, "ultrasonic treatment for 1 h" is replaced by "ultrasonic treatment for 45 min" and "ultrasonic treatment for 75 min", respectively. The other steps are the same, and characteristic spectra of three ultrasonic time are obtained, as shown in FIG. Figure 3 As shown by Figure 3(From top to bottom, they are 75 min, 1 h, and 45 min respectively) It can be seen that there is no obvious difference in the peak shape and separation effect of each characteristic peak with different ultrasonic extraction times. Considering the durability of the method, the optimal ultrasonic time is 1 h.
[0052] Example 4 The detection steps in this embodiment are the same as those in embodiment 1. In step (2) of embodiment 1, the "mixed solution of chloroform-methanol (volume ratio 4:1)" in the preparation of the test solution is replaced by "mixed solution of dichloromethane-methanol (volume ratio 4:1)". The other steps are the same. The characteristic spectra of the two extraction solvents are as follows: Figure 4 As shown by Figure 4 (From top to bottom, chloroform-methanol mixed solution is used as the extraction solvent, and dichloromethane-methanol mixed solution is used as the extraction solvent) It can be seen that when the chloroform-methanol (volume ratio 4:1) mixed solution is used as the extraction solvent, the response values of each characteristic peak are relatively high, and the chloroform-methanol (volume ratio 4:1) mixed solution is preferably used as the extraction solvent.
[0053] Example 5 The detection steps in this embodiment are the same as those in embodiment 1. In step (2) of embodiment 1, "60% ethanol" in the preparation of the test solution is replaced by "30% ethanol", "80% ethanol", "30% methanol", "60% methanol" and "80% methanol", respectively. The other steps are the same. The characteristic spectra of the six extraction solvents are obtained, as shown in FIG. Figure 5 As shown, Figure 5 From top to bottom, the order is 80% methanol, 60% methanol, 30% methanol, 80% ethanol, 60% ethanol, and 30% ethanol. The results of the different extraction solvents are shown in Table 2. Figure 5 It can be seen that when 30% ethanol and 80% ethanol are used as extraction solvents, the peak shape is poor and there are few peaks. When 30% methanol, 60% methanol, 80% methanol and 60% ethanol are used as extraction solvents, the response values of each characteristic peak are higher. Among them, when chloroform + 60% ethanol is used as the extraction solvent, the content of Fritillaria cirrhosae A and the ratio of Fritillaria cirrhosae A peak area to the maximum peak area are greater than those of the other extraction solvents. 60% ethanol is preferably used as the extraction solvent.
[0054] Table 2 Results of investigation on different extraction solvents
[0055] Methodological validation 2.1 System Applicability Take the reference solution of Example 1 and repeat the injection 6 times according to the chromatographic conditions of Example 1, record the chromatogram, calculate the RSD of the retention time and peak area of platycodon saponin D, and record the theoretical plate number. Figure 6(From bottom to top are the chromatograms of parallel samples corresponding to system suitability solutions 1-6). The results are shown in Table 3. The RSD of the platycoside D peak area was 1.6%, less than 4.0%, and the RSD of the retention time was 0.02%, less than 1.0%. The theoretical plate number of the platycoside D peak was greater than 3000, indicating good system suitability.
[0056] Table 3 System suitability investigation results
[0057] 2.2 Exclusivity Take the blank auxiliary material solution, reference solution and test solution of Example 1, inject them into the liquid chromatograph according to the chromatographic conditions of Example 1, and record the chromatogram. Figure 7 As shown, Figure 7 The chromatograms in the figure, from top to bottom, are for the test solution, reference solution, and blank excipient solution. The results show that the test solution has chromatographic peaks corresponding to the reference peaks, while the blank excipient has no chromatographic peaks at the locations where the characteristic peaks occur. The blank excipient has no interference, indicating good method specificity.
[0058] 2.3 Repeatability According to the preparation method of the test solution in Example 1, 6 test solutions were prepared in parallel. According to the chromatographic conditions of Example 1, each solution was injected once, and the chromatogram was recorded. The platycodin D peak was taken as the S peak, and the RSD of the relative retention time (RRT) of each characteristic peak and the S peak was calculated. The repeatability comparison chart is shown in the figure below. Figure 8 (From bottom to top are the chromatograms corresponding to repeatable solutions 1-6), and the results are shown in Table 4. The RSDs of the relative retention times of the characteristic peaks were between 0.0% and 1.0%, all less than 5.0%, indicating good repeatability.
[0059] Table 4 Repeatability test results
[0060] 2.4 Intermediate precision Different analysts used different liquid chromatographs and prepared 6 test solutions in parallel according to the preparation method of the test solution in Example 1. Each solution was injected once according to the chromatographic conditions of Example 1, and the chromatogram was recorded. The platycodin D peak was taken as the S peak, and the RSD of the relative retention time of each characteristic peak and the S peak was calculated. The comparison chart of the intermediate precision of the 6 injections is shown in Figure 2. Figure 9The results are shown in Table 5. In Table 5, the data for Personnel A refer to the results of the "2.3 Repeatability" test, while those for Personnel B refer to the intermediate precision test results. The results showed that the RSD values for the relative retention times of each characteristic peak and the S peak in six results measured by different analysts at different times on different instruments were within a range of 0.05%-1.0%. For a total of 12 results measured by different analysts, the RSD values for the relative retention times of each characteristic peak and the S peak were within a range of 0.3%-1.0%. The relative retention times for the six results measured individually by different analysts and the 12 results measured by two people together were all less than 5.0%, indicating good intermediate precision of this method.
[0061] Table 5 Intermediate precision and precision inspection results
[0062] 2.5 Stability of test solution Take the test solution of Example 1 and measure it according to the chromatographic conditions of Example 1 at 0h, 2h, 4h, 8h, 12h, 24h, 36h and 48h respectively. Record the relative retention time of each characteristic peak and S peak to investigate the stability of the solution. Figure 10 As shown in the figure (from bottom to top are 0h, 2h, 4h, 8h, 12h, 24h, 36h, and 48h chromatograms), the results are shown in Table 6. The RSDs of the relative retention times of the characteristic peaks are between 0.04% and 0.2%, all less than 4.0%, indicating that the test solution has good stability.
[0063] Table 6 Test solution stability results
[0064] 2.6 Durability The reference solution and the test solution of Example 1 were taken to investigate the column temperature, flow rate, and triethylamine concentration in the mobile phase B in the chromatographic conditions of Example 1 within a certain range, as well as the durability of different chromatographic columns. The parameters of the durable chromatographic conditions are shown in Table 7, and the experimental results are shown in Tables 8 to 11. The corresponding chromatograms are shown in Table 11. Figure 11-14 shown. Figure 11 This is a comparison chart of column temperature durability (from top to bottom: 35℃, 33℃, 37℃). Figure 12 This is a comparison chart of flow rate durability (from top to bottom: 1.0ml / min, 1.1ml / min, 0.9ml / min). Figure 13 This is a comparison chart of the durability of triethylamine concentration in mobile phase B (from top to bottom: 0.01% triethylamine, 0.008% triethylamine, 0.012% triethylamine). Figure 14 This is a comparison chart of the durability of different chromatographic columns (from top to bottom: column 1, column 3, column 2).
[0065] Table 7 Durability chromatographic condition variation parameters
[0066] Table 8 Column temperature durability test results
[0067] Table 9 Flow rate durability test results
[0068] Table 10 Durability test results of triethylamine concentration in mobile phase B
[0069] Table 11 Column durability test results
[0070] Depend on Figure 11-14 As can be seen, the RSDs of the relative retention times of each characteristic peak and the S peak were all less than 5.0% under different conditions of column temperature, flow rate, and triethylamine concentration in mobile phase B, demonstrating the robustness of this method. Peak 5 was not detected in the chromatogram of the sample using column 3, indicating that column 3 (Waters XSelect HSS T3 C18, 4.6 mm × 250 mm, 5 μm (SN: 01933317912440)) is not suitable for this method. The RADs of the relative retention times of each characteristic peak and the S peak were all less than 5.0% across columns of the same model but different batches, demonstrating the robustness of this column.
Claims
1. A method for detecting characteristic patterns of Qingjin Huatan granules, characterized in that: The following steps are involved: (1) Prepare a reference solution with platycodon saponin D reference substance; (2) Prepare the test solution with Qingjin Huatan granules; (3) Inject the reference solution, the test solution, and the blank excipient solution into a liquid chromatograph according to the following chromatographic conditions for measurement, obtain the chromatograms of the reference solution and the test solution, and compare the retention times to obtain the characteristic spectrum of Qingjin Huatan Granules; The chromatographic conditions are as follows: the chromatographic column uses octadecylsilane bonded silica gel as a filler, an evaporative light scattering detector is used, acetonitrile is used as mobile phase A, 0.008%-0.012% triethylamine solution is used as mobile phase B, gradient elution is performed, the flow rate is 0.9mL / min-1.0mL / min; and the column temperature is 33°C-37°C.
2. The Qingjin Huatan granule characteristic spectrum detection method according to claim 1, characterized in that: The reference solution in step (1) uses ethanol solution or methanol solution to dissolve the platycodon saponin D reference substance.
3. The method for detecting the characteristic spectrum of Qingjin Huatan granules according to claim 1, characterized in that: Preparation of the test solution in step (2): first soak the Qingjin Huatan granules with ammonia water, then add a mixed solution of chloroform-methanol or dichloromethane-methanol, treat with ultrasound or reflux for 45min-75min, filter, evaporate the liquid, and make up to volume with ethanol solution or methanol solution.
4. The method for detecting the characteristic spectrum of Qingjin Huatan granules according to claim 1, characterized in that: The blank auxiliary material solution in step (3) is obtained by dissolving maltodextrin in ethanol solution or methanol solution.
5. The method for detecting the characteristic spectrum of Qingjin Huatan granules according to claim 1, characterized in that: The gradient elution conditions of step (3) are: From 0 to 20 min, the volume fraction of mobile phase A changes from 20% to 25%, and the volume fraction of mobile phase B changes from 80% to 75%; 20-25min, the volume fraction of mobile phase A changes to 25%-25%, and the volume fraction of mobile phase B changes to 75%-75%; From 25 to 43 min, the volume fraction of mobile phase A changed from 25% to 40%, and the volume fraction of mobile phase B changed from 75% to 60%; From 43 to 55 min, the volume fraction of mobile phase A changed from 40% to 70%, and the volume fraction of mobile phase B changed from 60% to 30%; From 55 to 75 min, the volume fraction of mobile phase A changed to 70%-70%, and the volume fraction of mobile phase B changed to 30%-30%.
6. The method for detecting the characteristic spectrum of Qingjin Huatan granules according to claim 1, characterized in that: The chromatographic conditions of step (3) also include: the theoretical plate number required for system suitability is not less than 3000 calculated based on the platycodon saponin D peak.
7. The Qingjin Huatan granule characteristic spectrum detection method according to claim 1, characterized in that: The chromatographic column was Thermo Acclaim™ 120 C18.
8. The Qingjin Huatan granule characteristic spectrum detection method according to claim 1, characterized in that: The evaporative light scattering detector model of step (3) is SEDEX 85 evaporative light detector.
9. A characteristic spectrum obtained by the characteristic spectrum detection method of Qingjin Huatan granules according to any one of claims 1 to 8, characterized in that: The test solution showed 6 characteristic peaks, with peak 2, platycodon saponin D, as a reference. Peaks 1, 4 and 5 were derived from Anemarrhena asphodeloides, peaks 2 and 3 were derived from Platycodon grandiflorum, and peak 6 was derived from Fritillaria thunbergii.
10. The characteristic spectrum obtained by the characteristic spectrum detection method of Qingjin Huatan granules according to claim 9 is characterized in that: The 6 characteristic peaks were compared with the reference substances of timosaponin BⅡ, platycodon saponin D, timosaponin AⅢ and fritillarin A, and it was found that peak 1 was timosaponin BⅡ, peak 2 was platycodon saponin D, peak 5 was timosaponin AⅢ and peak 6 was fritillarin A.
Citation Information
Patent Citations
Method for constructing feature fingerprint spectrum of intermediate product of rhizoma gastrodiae and ligusticum wallichii particles
CN103760287A
Method for establishing fritillary bulb medicinal material alkaloids fingerprint
CN106124677A
Method for constructing HPLC (High Performance Liquid Chromatography) characteristic chromatogram of
CN115469028A
Establishment and detection method of UPLC specific chromatogram of compound apocynum venetum granules
CN116399972A
Separation method, characteristic chromatogram and construction method of five substances in fritillaria pallidiflora
CN117110464A
Cited By
Establishment method of high performance liquid characteristic chromatogram of phlegm reducing preparation and component content determination method
CN120609945A
Establishment of a method for high performance liquid chromatography (HPLC) characteristic chromatogram of a Huatan prescription preparation and a method for determining the content of components
CN120609945B
